Caffeine as a preventive supplement for Parkinson’s disease: A meta-analysis

Clicks: 1
ID: 284773
2023
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal

Ranked #3,286 of 3,757 articles by views in Malay Journal

Most read Least read

Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 3,757 in total.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Abstract
Parkinson’s disease (PD), which remains with no cure, is the second most prevalent neurodegenerative disease. However, there is growing speculation that caffeine consumption may reduce the risk and progression of PD. The potential of caffeine to provide neuroprotection against PD was determined through a meta-analysis, with four exploring the effect between caffeine and the risk of PD, while three studies focused on caffeine's impact on the progression of the disease. The study findings indicated that caffeine consumption was significantly associated with both a lower risk (RR = 0.70, 95% CI, p
Reference Key
persistent_1760653640_68f171485824e Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Oronce, Luis Reyes
Journal Malay Journal
Year 2023
DOI
DOI not found
URL
Keywords Keywords not found

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

No comments yet. Be the first to comment on this article.